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esponsibility of Xi’Abstract Oral estrogens are directly associated with changes in plasma levels of coagulation proteins. Thus,
the detection of any variation in protein concentrations due to estrogen contraceptives, by a simultaneous
analysis of both coagulation proteins and estrogens, would be a very informative tool. In the present study, the
merit of photo-selected reaction monitoring (SRM), a new analytical tool, was evaluated towards estrogens
detection in plasma. Then, SRM and photo-SRM detection modes were combined for the simultaneous
analysis of estrogen molecules together with heparin co-factor and factor XIIa, two proteins involved in the
coagulation cascade. This study shows that photo-SRM could open new multiplexed analytical routes.
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Oral contraceptives were introduced in the late 1950s and became
one of the most popular contraceptive tools. However, it is now
well known that the use of hormonal contraceptives such as
estrogens is associated with an increased risk of thromboembolic
events [1–3]. Indeed, oral estrogens, and in particular ethinyl
estradiol (EE2), are directly associated with changes in plasma
levels of many coagulation proteins [4,5]. Hence, simultaneousier B.V. All rights reserved.
Q. Enjalbert et al.184quantiﬁcation of proteins involved in the coagulation process and
level of circulating estrogen could be interesting for deciphering
the relationship between estrogens and imbalance of coagulation
homeostasis. The merits of liquid chromatography coupled to
tandem mass spectrometry (LC–MS/MS) in selected reaction
monitoring (SRM) mode have been widely illustrated for natural
or synthetic estrogens analysis in plasma [6–8], and in urine [9] or
in waste water [10–12]. The described methods usually involve
estrogens derivatization with dansyl chloride in order to achieve
the lowest limits of quantiﬁcation (LOQ), typically in the pg/mL
range, [6,12,13]. Another possibility consists of the use of 2D
chromatography without derivatization [14]. Furthermore, most of
these methods combine a liquid/liquid extraction (LLE), a solid-
phase extraction (SPE) or a precipitation step to remove the bulk
of plasma proteins [13,15,16]. However, such sample workﬂow
does not appear suitable when protein levels are also informative.
Recently, there have been reports of how protein assay associated
with targeted mass spectrometry through the quantiﬁcation of a
proteotypic peptide is a promising alternative to immunotesting
[17–22]. On the other hand, assay development for weakly
concentrated proteotypic peptides is much more complex owing
to sample complexity and dynamic concentration range of the
whole proteome trypsin digest. Signiﬁcant improvements of
detection speciﬁcity have been recently obtained by introducing
either an additional fragmentation step [23,24] or an accurate
measurement of the fragment ions [25]. Another alternative
strategy called photo-SRM [26,27] proposes the implementation
of a laser photo-dissociation in a classical triple quadrupole in order to
selectively fragment only chromophore-tagged compounds. In the
present study, we combined for the ﬁrst time a conventional collision
fragmentation and a photo-dissociation fragmentation in a SRM mode
for the simultaneous detection of estrogens and coagulation protein
factors within a single chromatographic run.2. Experimental
2.1. Reagents and chemicals
Acetonitrile (ACN), methanol (MeOH) and water (LC–MS grade)
were obtained from Fisher Scientiﬁc (Strasbourg, France). Dithio-
threitol (DTT), iodoacetamide (IAM), formic acid (FA) (LC–MS
grade), trypsin (type IX-S from Porcine Pancreas), urea, ammonium
bicarbonate (AMBIC), tris(2-carboxyethyl)phosphine (TCEP), sodium
bicarbonate (NaHCO3), sodium hydroxide (NaOH) and dabsyl chloride
were purchased from Sigma-Aldrich (St Quentin-Fallavier, France).
The pools of human plasma (men or menauposal women) wereFig. 1 (A) Schematic of the experimental set-up. (B) Chemical structure o
is shown.obtained from the Institut Pasteur (Lille, France). Internal standards
estradiol-d2 (E2D2, purity¼97%) and ethinyl estradiol-d4 (EE2D4,
purity¼97%) were obtained from CDN isotopes (Pointe-Claire,
Canada).
2.2. Instrumentation
SRM and photo-SRM analyses were performed on a 4000
QTRAPs mass spectrometer (AB Sciex, Foster City, CA)
equipped with a Turbo V™ ion source coupled to an Agilent
1290 series high pressure liquid chromatography (Agilent Tech-
nologies, Waldbronn, Germany). A schematic of the photo-SRM
set-up is given in Fig. 1A [27]. A quartz window was ﬁtted on the
rear of the MS instrument chamber to allow the introduction of a
laser beam. The laser was a 473 nm continuous wavelength laser
(cw) (ACAL BFI, Evry, France). The laser output power of the
laser was 500 mW with a beam diameter of 0.6 mm (divergence
1.2 mrad). The laser beam passed through a single diaphragm and
is injected into the MS instrument using two mirrors. To avoid
fragmentation in Q1 and Q3, the laser beam was slightly off-axis
(0.21).
2.3. HPLC operating conditions
The HPLC separation was carried out on an Xselect™ C18 column
(100 mm 2.1 mm, 3.5 mm) from Waters (Milford, MA, USA).
The mobile phase consisted of water containing 0.1% (v/v) formic
acid as eluent A and ACN containing 0.1% (v/v) formic acid as eluent
B. Twenty microlitre of each sample were injected for both
analytical methods. For analysis of estrogens alone, elution was
performed at a ﬂow rate of 300 mL/min for 5 min with an isocratic
elution of 5% of eluent A and 95% of eluent B. The simultaneous
analysis of peptides and estrogens were performed during 16 min
with an elution including a 2 min isocratic period with 95% of
eluent A, followed by a 6 min linear gradient from 95% to 70% of
eluent A and a column washing at 100% of eluent B for 4 min.
The gradient returned to the initial conditions for 4 min, before the
next injection.
2.4. Mass spectrometry operating conditions
Ionization was achieved using electrospray in positive ionization
mode with an ion spray voltage of 5500 V. The following
conditions were found to be the optimal conditions for the analysis
of E2 and EE2 in SRM and photo-SRM methods. The curtain gas
ﬂow (nitrogen), the ion source gas 1 and 2 (air) were respectivelyf E2 estradiol coupled with dabsyl chloride, main fragment at 225 m/z
CID and photo-SRM MS for simultaneous analysis of coagulation factors and estrogens 185set at 15, 50 and 20 arbitrary units. The Turbo ion spray source
was operating at 450 1C. Q1 and Q3 quadrupole resolutions were
adjusted to 0.770.1 amu. Collision energy (CE) was set to 40 eV
for CID experiments and to 5 eV for photo-SRM (to avoid CID).
For complex analyses, a mass spectrometry method with two
different periods, over the analysis time, was developed. The ﬁrst
period from 0 to 8 min was developed to analyze common
proteotypic peptides and the following experimental conditions
were optimized for peptide quantiﬁcation using MRM Pilot
software™ (AB Sciex, Foster City, CA, USA). Ionization was
achieved using electrospray in positive ionization mode with an
ion spray voltage of 5500 V. The curtain gas ﬂow (nitrogen), the
ion source gas 1 and 2 (air) were respectively set at 50, 50 and 20
units. The Turbo ion spray source was operating at 450 1C.
Collision energies and SRM transitions are shown in Table S1
(Electronic supplementary material). Q1 and Q3 quadrupole
resolutions were adjusted to 0.770.1 amu. The second period,
from 8 to 16 min was developed to analyze estrogens. The source
and mass spectrometry conditions used for SRM and photo-SRM
methods were the same as those for the rapid analysis.In
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Fig. 2 LC–MS/MS chromatograms tracking down either E2D2
(SRM transition 562.5/225.0, spiked at 20 pg/mL) in human plasma
obtained following photo-SRM and SRM analyses (A), or EE2D4
(SRM transition 588.5/225.0, spiked at 50 pg/mL) in human plasma
obtained following photo-SRM and SRM analyses (B). The arrows
show target molecules.2.5. Sample preparation
Prior to any sample preparation, a concentration range of 0, 200,
500, 2000, 5000, 10,000 and 20,000 pg/mL of estrogen internal
standards were prepared in a solution of sodium bicarbonate buffer
(100 mM, pH adjusted to 10 with NaOH).
For rapid estrogens analyses, 10 mL of each estrogen internal
standard solution were spiked in 90 mL of plasma to obtain a
concentration range of 0, 20, 50, 200, 500 and 2000 pg/mL. Nine
hundred microlitre of ACN were then added to each sample to
precipitate proteins. Then, samples were centrifuged (10 min,
15,000 rpm, room temperature (RT)) and 900 mL of the upper
layer were collected and concentrated to dryness under a stream of
nitrogen. The residue of each tube was redissolved in 70 mL of
sodium bicarbonate buffer (100 mM, pH adjusted to 10 with
NaOH) followed by vortex-mixing for 1 min. To each sample,
30 mL of dabsyl chloride solution (1 mg/mL in acetone) were
added followed by vortex-mixing for 1 min. Samples were placed
in a 60 1C incubator for 10 min, then cooled and stored at 4 1C
before analysis. Triplicates of each standard were realized.
For complex analysis, 10 mL of each solution of estrogen
internal standards were spiked in 90 mL of plasma to obtain a
range of concentration of 0, 20, 50, 200, 500, 1000 and 2000 pg/
mL. For peptide alkylation and estrogen derivatization, samples
were denatured with 400 mL of 8 M urea (pH¼10). 55 mL of
150 mM dithiothreitol and 100 mL of dabsyl chloride solution
(1 mg/mL in acetone) were added to the samples before warming-
up at 60 1C for 40 min. Samples were cooled to RT and alkylated
with 170 mL of 150 mM iodoacetamide at RT in the dark for
40 min. To reduce the urea concentration, the samples were diluted
5-fold with AMBIC (50 mM) prior to overnight digestion at 37 1C
with trypsin using a 1:30 (w/w) enzyme to substrate ratio. All
samples were desalted and concentrated using Oasis™ HLB 3 cm3
(60 mg) reversed phase cartridges (Waters, Milford, MA, USA).
Before loading the tryptic digest onto the Oasis cartridges, all
cartridges were conditioned with 1 mL of MeOH and 1 mL of
water containing 0.5% FA. After the loading, all cartridges were
washed with 1 mL of MeOH/water (5/95, v/vþ0.5% FA) and
eluted with 2 mL of ACN containing 0.5% FA. The samples were
evaporated to dryness under a stream of nitrogen. The residue ofeach tube was redissolved in 100 mL of sodium bicarbonate buffer
(100 mM, pH adjusted to 10 with NaOH) followed by vortex-
mixing for 1 min. Samples were cooled and stored at 4 1C until
analysis.3. Results and discussion
3.1. Comparison of SRM and photo-SRM for single estrogen
analysis
Tandem mass spectrometry analyses on a triple quadrupole
analyzer are based on the collision induced dissociation (CID)
process with a detection speciﬁcity brought through two mass
selections in Q1 and Q3 (called SRM transition). Usually, CID-
SRM selectivity is sufﬁcient for quantiﬁcation of small molecules.
However, in complex matrices such as plasma or serum after
trypsin digestion, co-eluted interferences with the same SRM
transition can be detected. In order to add a new selectivity step,
the CID process has been substituted with laser induced dissocia-
tion (LID), allowing measurement by LID-SRM or photo-SRM.
Indeed, the CID process is a non-discriminating fragmentation
mode where all ions selected in Q1 are fragmented while LID can
Q. Enjalbert et al.186only be used after the molecules have absorbed photons of the
chosen wavelength. The majority of biomolecules available in
plasma or serum do not absorb in the visible wavelength range, so
the use of a laser emitting at 473 nm photo-fragments exclusively
molecules absorbing at this wavelength. Thus, in order to bring the
correct optical properties to estrogens, a chromophore-
derivatization is required. The dansyl chloride chromophore,
usually used for estrogens derivatization, does not absorb at
473 nm, so it has been substituted with the dabsyl chloride
chromophore [28]. Gas phase optical spectra, recorded on a linear
ion trap coupled with an optical parametric oscillator laser [29–31],
showed a high absorption at 473 nm with a λmax¼490 nm
(Fig. S1 in electronic supplementary material).
Prior to simultaneous analysis of estrogens and proteins in the
same run, the beneﬁt of photo-SRM has been evaluated and
compared with the basic CID-SRM method for the quantiﬁcation
of estrogens in plasma samples. Thus, a wide concentration range
of internal standards E2D2 and EE2D4 (0–2000 pg/mL) has been
prepared in senior women plasma. LID and CID spectra of the
derivatized estrogens resulted in an intense fragment ion at m/z
225, corresponding to a fragmentation within the chromophore
(see Fig. 1B). The couple precursor ion/fragment ion ([derivatized
estrogenþH]þ/225) was used in both SRM methods for theFig. 3 Calibration curves of SRM (in black ■) and photo-SRM (in red
Insets show low concentrations (0–250 pg/mL).analysis of derivatized estradiol compound E2D2 (Fig. 2B) and
derivatized ethinyl estradiol compound EE2D4 (Fig. 2B).
As shown in Fig. 2, following plasma precipitation, no major
interference was detected either in CID-SRM (solid line) or in
photo-SRM channel (dotted line). For estradiol, the signal inten-
sities were similar in both methods while the photo-SRM signal
detected for ethinyl estradiol was slightly improved in comparison
to the SRM. These results show that photo-SRM could be an
alternative to CID-SRM for quantitation of estrogens, especially in
very complex matrix as it will be illustrated in Section 3.2.
In addition, both estrogens were either spiked before or after the
protein depletion by precipitation and the signal intensities were
compared to detect any loss of target molecules due to the
precipitation. No major signal difference was observed, indicating
that estrogen quantiﬁcation was not biased by protein precipitation
process. Calibrations curves of SRM and photo-SRM transitions
obtained for estradiol and ethinyl estradiol compounds are shown
in Fig. 3. The experiments have been performed in triplicate over
the full experimental sample workﬂow (i.e., chromophore tagging,
sample precipitation). The calculated linearity shows that robustness
and repeatability can be validated for the whole analytical process.
Back calculated accuracies (accuracies are expressed as percent
difference) also show good robustness and repeatability with▲) transition obtained for the analyses of E2D2 (A) and EE2D4 (B).
Fig. 4 LC–MS/MS chromatograms tracking down coagulation proteins and estrogens in two different periods. From 0 to 8 min, 2 SRM
transitions for heparin cofactor (RT¼6.5 min) and 2 SRM transitions for coagulation factor XIIa HC (RT¼7.1 min). From 8 to 16 min, ethinyl
estradiol either in SRM mode (black line) or in photo-SRM mode (red line) SRM transition 588.5/225.0, spiked at 500 pg/mL, RT¼11.9 min in
human plasma. All * represent interferences detected in SRM and photo-SRM modes.
CID and photo-SRM MS for simultaneous analysis of coagulation factors and estrogens 187values lower than 15% over the whole concentration range. The
two methods are thus comparable for the quantiﬁcation and
detection of target molecules. However, previous publications
demonstrated that photo-SRM is more interesting in the case of
very complex matrix, such as digested plasma, where peptides and
small molecules are still present [26].
3.2. Simultaneous analysis
Once the proof of concept for photo-SRM estrogen analysis has
been done, a detection of labeled estrogens and coagulation
proteins has been performed to measure simultaneously both
biomolecules from the same sample during the same run. In order
to avoid any variation of coagulation protein concentrations, a pool
of menauposal female plasma has been chosen. As all target
molecules have to be retained in the same fraction, the precipita-
tion process has been replaced by a classic protein quantiﬁcation
protocol digesting proteins into peptides as described in Section 2.
Traditionally, estrogens derivatization is made in sodium bicarbo-
nate buffer. However, urea (8 M, pH¼10), which also acts as
denaturant before protein digestion, was directly used as deriva-
tization buffer. The LC method for simultaneous analysis was
sequenced in two different periods of 8 min each. The ﬁrst period
consisted of a CID-SRM analysis of proteotypic peptides of
two coagulation proteins (Coagulation factor XIIa HC and
Heparin Cofactor). SRM transitions values of proteotypic peptides
are based on commonly used values reported by Hortin et al. [32].
The two targeted peptides were detected in CID-SRM on a time scale
shorter than 8 min (less than 30% of eluent B) as they are less
hydrophobic than the derivatized estrogens. Fig. S2 (in electronic
supplementary material) shows MS/MS experiments performed to
identify the two proteotypic peptides while Table S1 (in electronic
supplementary material) shows SRM transitions collision energies
used for CID fragmentation, chromatographic peak heights, chromato-
graphic peak areas and retention times recorded for the two
proteotypic peptides. The second period of the LC methodconsisted in the analysis of estrogens compounds either in SRM
or photo-SRM.
Fig. 4 shows the whole reconstructed chromatogram tracking
down, from 0 to 8 min, the two endogenous coagulation proteins
(Coagulation factor XIIa HC and Heparin Cofactor) by SRM and
from 8 to 16 min, the ethinyl estradiol compound recorded in SRM
or photo-SRM. Major interferences were detected between 8 and
12 min during the SRM method, especially through the estrogen
elution. This is due to the fact that, compared with the ﬁrst
experiment measuring only estrogens, proteins were not precipi-
tated during the sample preparation and are still present. On the
other hand, almost no interfering peaks are detected during the
photo-SRM mode. The comparison of both methods clearly shows
the drastic simpliﬁcation of chromatograms obtained with photo-
SRM vs. SRM, proving that classical SRM detection speciﬁcity is
not high enough for a simultaneous detection. As a consequence,
the increased speciﬁcity of the photo-dissociation process could
extend the response linearity in case of co-eluting compounds
from the complex matrix. In this preliminary results, analytical
validation on proteins was not performed, however multiplexed
quantitative proteomics have been well described and are com-
monly used [33,34]. Thus, further experiments involving several
coagulation proteins and estrogens should be performed in
future work.4. Conclusion
Here is presented a new application of the photo-SRM mode for
the detection and quantiﬁcation of estrogens in complex matrices.
For single estrogen quantiﬁcation, photo-SRM method is as
sensitive as classic SRM mode without any loss of speciﬁcity or
sensitivity. Moreover, in a case of a simultaneous analysis of small
molecules and proteins, in very complex matrices, CID-SRM
combined to photo-SRM could improve the detection speciﬁcity of
estrogens as a result of a more speciﬁc fragmentation step and by
Q. Enjalbert et al.188the increased hydrophobicity of chromophore derivatized com-
pounds. These results are very encouraging and in perspective, the
mass spectrometer sensitivity could be increased by implementing
the photo-SRM method in a last generation triple quadripole.
Finally, the single use of photo-SRM method could be applied for
the simultaneous detection of peptides and small molecules. In that
case, we should either use the same chromophore (such as dabsyl
chloride) for small molecules and peptides to detect all biomole-
cules with a phenol function or use two different chromophores to
tag two different chemical functions. Thus, new analytical routes
could be investigated as “metabo-proteomics” analysis.Appendix A. Supporting information
Supplementary data associated with this article can be found in the
online version at http://dx.doi.org/10.1016/j.jpha.2013.09.004.References
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